R&D

OmniaMed Co., Ltd. opens up a new paradigm for the development of treatments using Nitric Oxide functionality.

Tech3

Small molecule
Brain tumor
  • Temozolomide
  • Carboplatin
Alzheimer’s
  • Donepezil
  • Memantine
Antibody
뇌종양
Bevacizumab (VEGF)
Cetuximab (EGFR)
Alzheimer’s
Aducanumab (late stage Aβ)
BAN2401 (early stage Aβ)
Nanomedicine
Brain tumor
DOXIL
Abraxane
Alzheimer’s
OM-101 (OmniaMed)
  • BBB is a tight junction cell membrane distributed in blood vessels in the brain.
  • BBB acts as a barrier to prevent substances in the blood from entering brain tissue and protects the brain under normal circumstances.
  • However, if there is an abnormality in brain tissue and the drug needs to be delivered, the drug's delivery efficiency is hindered by BBB.
  • Therefore, the drug's BBB penetration rate makes or breaks treatment of brain disease.
  • Tech 3 is a technology that releases NO from blood vessels in the brain to temporarily open BBB and improves the delivery efficiency of existing treatments.